Biotech

All Articles

Gene editor Tome laying off 131 employees

.Only times after gene publisher Tome Biosciences announced unrevealed operational slices, a more cl...

Repare gives up 25% of staff as biotech standstills preclinical R&ampD

.Repare Therapeutics is giving up a fourth of its own workforce as the oncology biotech lessen its p...

J &amp J apply for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten one more step towards realizing a yield on its $6.5 billio...

Gain's phase 1 succeed leads means to verify Parkinson's drug's worth

.Gain Rehabs has set its sights on confirming the performance of its own Parkinson's condition thera...

Actinogen reports brand-new period 2 records to recover depression medication

.Actinogen Medical's hopes-- as well as inventory price-- have actually rebounded somewhat coming fr...

Pfizer as well as Flagship include Quotient to multibillion-dollar formula

.Main Pioneering and also Pfizer have added Ratio in to their 10-program relationship, inking a deal...

Bayer pens $547M pact to drive borders of noncoding RNA

.Bayer managers were keen to anxiety to Brutal this summer that the German pharma giant's hunger for...

UK introduces strategies to introduce 18 brand-new clinical trial hubs

.In the middle of a yearslong medical trial decrease in the U.K., a brand-new public-private relatio...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology analysis device

.Following the announcement of a big unemployment round in April and also a major restructuring proj...

Neurocrine's KarXT opponent reaches in stage 2-- yet merely at low dose

.Neurocrine Biosciences has actually accomplished its own hoped-for profile in a stage 2 schizophren...